242 related articles for article (PubMed ID: 2867214)
21. Vasoconstricting effect of vasopressin on regional vascular beds in conscious rats after ganglionic blockade.
Teranishi Y; Shimamoto Y; Fujii T
Hiroshima J Med Sci; 1993 Jun; 42(2):83-8. PubMed ID: 7902831
[TBL] [Abstract][Full Text] [Related]
22. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
23. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
Shen YT; Pittman TJ; Buie PS; Bolduc DL; Kane SA; Koblan KS; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
[TBL] [Abstract][Full Text] [Related]
24. Possible contribution of central gamma-aminobutyric acid receptors to resting vascular tone in freely moving rats.
Takemoto Y
Exp Physiol; 2000 Sep; 85(5):479-85. PubMed ID: 11038398
[TBL] [Abstract][Full Text] [Related]
25. Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats.
Janssen BJ; Kam KL; Smits JF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):414-21. PubMed ID: 11692224
[TBL] [Abstract][Full Text] [Related]
26. V1 receptor activation induced by hemorrhage and sympathoinhibition in the mesentery and hindquarters of spontaneously hypertensive rats.
Xing CH; Teranishi Y
Hiroshima J Med Sci; 2005 Dec; 54(4):93-9. PubMed ID: 16398053
[TBL] [Abstract][Full Text] [Related]
27. Regional hemodynamic effects of the beta-adrenoceptor blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
Nievelstein HM; Tijssen CM; Smits JF; Struyker-Boudier HA
Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):118-29. PubMed ID: 2876684
[TBL] [Abstract][Full Text] [Related]
28. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
[TBL] [Abstract][Full Text] [Related]
29. Decreased vascular resistance after intra-arterial injection of [met]enkephalin in the hindquarters of conscious rabbits.
Wightman JM; Schadt JC; Gaddis RR
J Pharmacol Exp Ther; 1987 Apr; 241(1):314-20. PubMed ID: 3572793
[TBL] [Abstract][Full Text] [Related]
30. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
Kost CK; Herzer WA; Li P; Jackson EK
J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
[TBL] [Abstract][Full Text] [Related]
31. Regional vasodilator actions of calcitonin gene-related peptide in conscious SHR.
Lappe RW; Todt JA; Wendt RL
Peptides; 1987; 8(4):747-9. PubMed ID: 3498157
[TBL] [Abstract][Full Text] [Related]
32. Neurogenic vasodilatation produced by fenoldopam in the rat hindquarters vascular bed.
Van der Niepen P; Lefebvre RA; Dupont AG
J Auton Pharmacol; 1987 Dec; 7(4):331-8. PubMed ID: 2895108
[TBL] [Abstract][Full Text] [Related]
33. Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.
Berecek KH; Nagahama S; Oparil S
J Hypertens Suppl; 1984 Dec; 2(3):S63-6. PubMed ID: 6100756
[TBL] [Abstract][Full Text] [Related]
34. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.
Montier F; Katchadourian P; Pratz J; Cavero I
J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522
[TBL] [Abstract][Full Text] [Related]
35. Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
Brooks DP; DePalma PD; Cyronak MJ; Bryant MA; Karpinski K; Mico B; Gaitanopoulos DE; Chambers PA; Erhard KF; Weinstock J
J Pharmacol Exp Ther; 1990 Sep; 254(3):1084-9. PubMed ID: 1975620
[TBL] [Abstract][Full Text] [Related]
36. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
Dupont AG; Lefebvre RA; Vanderniepen P
Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
[TBL] [Abstract][Full Text] [Related]
37. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
Kohli JD; Glock D; Goldberg LI
J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
[TBL] [Abstract][Full Text] [Related]
39. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
McCoy CE; Douglas FL; Goldberg LI
Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
[TBL] [Abstract][Full Text] [Related]
40. Hypotensive and regional haemodynamic effects of fenoldopam and quinpirole in the anaesthetized rat.
Van der Niepen P; Dupont AG; Finne E; Six RO
J Hypertens Suppl; 1988 Dec; 6(4):S687-9. PubMed ID: 2907350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
